PetzoldAde BoerJFSchipplingS. Optical coherence tomography in multiple sclerosis: A systematic review and meta-analysis. Lancet Neurol2010; 9: 921–932.
2.
GreenAJ. Getting beyond the ganglion cell: Morphometric adjustments for retinal optical coherence tomography in multiple sclerosis. JAMA Neurol2013; 70: 13–15.
3.
GreenAJMcQuaidSHauserSL. Ocular pathology in multiple sclerosis: Retinal atrophy and inflammation irrespective of disease duration. Brain2010; 133: 1591–1601.
4.
SaidhaSSotirchosESOhJ. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol2013; 70: 34–43.
5.
GelfandJMGoodinDSBoscardinWJ. Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One2012; 7: e36847.
6.
PulickenMGordon-LipkinEBalcerLJ. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology2007; 69: 2085–2092.
7.
BalkLTewariePKillesteinJ. Disease course heterogeneity and OCT in multiple sclerosis. Mult Scler J2014Jan8. [Epub ahead of print].
8.
GabilondoIMartínez-LapiscinaEHMartínez-HerasE. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol2014; 75: 98–107.
9.
KlistornerASriramPVootakuruN. Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions. Neurology2014; 82: 2165–2172.
10.
BalkLJSteenwijkMDTewarieP. Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. J Neurol Neurosurg Psychiatry2014; Jun27. pii: jnnp-2014-308189. doi: 10.1136/jnnp-2014-308189. [Epub ahead of print].
11.
TewariePBalkLCostelloF. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One2012; 7: e34823.
12.
SchipplingSBalkLCostelloF. Quality control for retinal OCT in multiple sclerosis: Validation of the OSCAR-IB criteria. Mult Scler J2014; Jun16. pii: 1352458514538110. [Epub ahead of print].